You are here

AstraZeneca explores potential transaction with Acerta

[PARIS] AstraZeneca Plc said it's exploring potential strategic options with Acerta Pharma BV, a maker of cancer medicines.

There can be no certainty that a "transaction will ultimately be entered into, or as to the terms of any transaction," the London-based company said in a statement.


Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom